![Jørgen Fischer Ravn](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
Jørgen Fischer Ravn worked as a Partner at Reliance A and as VP-Investor Relations & Communications at Bionor Pharma ASA from 2015 to 2016.
Former positions of Jørgen Fischer Ravn
Companies | Position | End |
---|---|---|
Bionor Pharma ASA
![]() Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | Investor Relations Contact | 01/09/2016 |
Reliance A/S
![]() Reliance A/S Miscellaneous Commercial ServicesCommercial Services Reliance A/S provides business consulting services. The company also provides services to the public and initial public offering companies. It offers advices in the areas such as investor relations, corporate finance, equity research, communication and operational and strategic issues. Reliance is headquartered in Copenhagen, Denmark. | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Reliance A/S
![]() Reliance A/S Miscellaneous Commercial ServicesCommercial Services Reliance A/S provides business consulting services. The company also provides services to the public and initial public offering companies. It offers advices in the areas such as investor relations, corporate finance, equity research, communication and operational and strategic issues. Reliance is headquartered in Copenhagen, Denmark. | Commercial Services |
Bionor Pharma ASA
![]() Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | Health Technology |
- Stock Market
- Insiders
- Jørgen Fischer Ravn